Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 60094-2-Ig - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#60094-2-Ig, RRID:AB_2163215
- Product name
- PFN2 antibody
- Antibody type
- Monoclonal
- Description
- PFN2 antibody (Cat. #60094-2-Ig) is a mouse monoclonal antibody that shows reactivity with human, mouse, rat, pig and has been validated for the following applications: IHC, WB,ELISA.
- Reactivity
- Human, Mouse, Rat, Porcine
- Host
- Mouse
- Conjugate
- Unconjugated
- Isotype
- IgG
- Antibody clone number
- 2H7C12
- Vial size
- 20ul, 150ul
Submitted references ets1 associates with KMT5A to participate in high glucose-mediated EndMT via upregulation of PFN2 expression in diabetic nephropathy.
NCAM regulates temporal specification of neural progenitor cells via profilin2 during corticogenesis.
Loss of profilinĀ 2 contributes to enhanced epithelial-mesenchymal transition and metastasis of colorectal cancer.
PFN2a, a new partner of RARĪ± in the cytoplasm.
Lu L, Zhong Z, Gu J, Nan K, Zhu M, Miao C
Molecular medicine (Cambridge, Mass.) 2021 Jul 8;27(1):74
Molecular medicine (Cambridge, Mass.) 2021 Jul 8;27(1):74
NCAM regulates temporal specification of neural progenitor cells via profilin2 during corticogenesis.
Huang R, Yuan DJ, Li S, Liang XS, Gao Y, Lan XY, Qin HM, Ma YF, Xu GY, Schachner M, Sytnyk V, Boltze J, Ma QH, Li S
The Journal of cell biology 2020 Jan 6;219(1)
The Journal of cell biology 2020 Jan 6;219(1)
Loss of profilinĀ 2 contributes to enhanced epithelial-mesenchymal transition and metastasis of colorectal cancer.
Zhang H, Yang W, Yan J, Zhou K, Wan B, Shi P, Chen Y, He S, Li D
International journal of oncology 2018 Sep;53(3):1118-1128
International journal of oncology 2018 Sep;53(3):1118-1128
PFN2a, a new partner of RARĪ± in the cytoplasm.
Andriamoratsiresy D, Piskunov A, Lutzing R, Rochette-Egly C
Biochemical and biophysical research communications 2018 Jan 1;495(1):846-853
Biochemical and biophysical research communications 2018 Jan 1;495(1):846-853
No comments: Submit comment
No validations: Submit validation data